Ishares Nasdaq Biotechnology Etf Fundamentals
| BTEC Etf | 6.58 0.13 2.02% |
iShares Nasdaq Biotechnology fundamentals help investors to digest information that contributes to IShares Nasdaq's financial success or failures. It also enables traders to predict the movement of IShares Etf. The fundamental analysis module provides a way to measure IShares Nasdaq's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IShares Nasdaq etf.
IShares |
iShares Nasdaq Biotechnology ETF Beta Analysis
IShares Nasdaq's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current IShares Nasdaq Beta | 0.84 |
Most of IShares Nasdaq's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, iShares Nasdaq Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, iShares Nasdaq Biotechnology has a Beta of 0.84. This is much higher than that of the family and significantly higher than that of the Sector Equity Biotechnology category. The beta for all United Kingdom etfs is notably lower than that of the firm.
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
As returns on the market increase, IShares Nasdaq's returns are expected to increase less than the market. However, during the bear market, the loss of holding IShares Nasdaq is expected to be smaller as well.
IShares Fundamentals
| Beta | 0.84 | |||
| One Year Return | 19.20 % | |||
| Three Year Return | 0.70 % | |||
| Five Year Return | 5.40 % |
About IShares Nasdaq Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze iShares Nasdaq Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IShares Nasdaq using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of iShares Nasdaq Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.IShares Nasdaq is entity of United Kingdom. It is traded as Etf on LSE exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in IShares Etf
IShares Nasdaq financial ratios help investors to determine whether IShares Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IShares with respect to the benefits of owning IShares Nasdaq security.